There have been no open-market insider trades at Allovir, Inc. in the last 12 months.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
There have been no open-market insider trades at Allovir, Inc. in the last 12 months.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Feb 24, 2025 | Sinha Vikas | Officer | Sell | 303 | $10.08 | $3K | SEC |
| Feb 24, 2025 | Hagen Brett R | Executive Officer | Sell | 96 | $10.08 | $968 | SEC |
| Feb 24, 2025 | Miller Edward | Executive Officer | Sell | 106 | $10.08 | $1K | SEC |
| Jan 27, 2025 | Miller Edward | Executive Officer | Sell | 47 | $9.45 | $444 | SEC |
| Jan 27, 2025 | Miller Edward | Executive Officer | Sell | 5 | $9.94 | $50 | SEC |
| Jan 27, 2025 | Hagen Brett R | Executive Officer | Sell | 4 | $9.94 | $40 | SEC |
| Jan 27, 2025 | Hagen Brett R | Executive Officer | Sell | 32 | $9.45 | $302 | SEC |
| Jan 27, 2025 | Sinha Vikas | Officer | Sell | 13 | $9.94 | $129 | SEC |
| Jan 27, 2025 | Sinha Vikas | Officer | Sell | 116 | $9.45 | $1K | SEC |
| Nov 20, 2024 | Hagen Brett R | Executive Officer | Sell | 554 | $0.55 | $305 | SEC |
| Nov 20, 2024 | Sinha Vikas | Officer | Sell | 3,186 | $0.55 | $2K | SEC |
| Nov 20, 2024 | Miller Edward | Executive Officer | Sell | 432 | $0.55 | $238 | SEC |
| Nov 20, 2024 | Brainard Diana | CEO | Sell | 8,706 | $0.55 | $5K | SEC |
| Nov 6, 2024 | Hagen Brett R | Executive Officer | Sell | 1,655 | $0.86 | $1K | SEC |
| Nov 6, 2024 | Sinha Vikas | Officer | Sell | 5,136 | $0.86 | $4K | SEC |
There were no open-market insider trades in ALVR in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in ALVR were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).